BioSpace News Archive

Business

Report: Investors Urge Ouster of Regeneron Director Over Executive Compensation

Two of the company’s largest shareholders call for the ouster of a company director at Regeneron as top executives are under fire for their enormous compensation packages.

June 10, 2021
·
2 min read
·
Alex Keown
Business

Funding News: Synthekine, Bright Peak Each Raise $107 Million in Series B Rounds

Synthekine and Bright Peak made announcements on their Series B rounds, while Hawthorne Effect and Owl Peak Labs also secured their funding. Let us take a look.

June 10, 2021
·
4 min read
·
Alex Keown
Drug Development

COVID-19 News Update: Moderna Files for EUA in Adolescents and More

Although the COVID-19 pandemic is waning in the U.S., there is still plenty of research and news about the disease. Here’s a look.

June 10, 2021
·
5 min read
·
Mark Terry
Business

Three Biopharma Companies Close Series A Financing Rounds

June appears to be a busy month for Series A financing rounds, with Kurome, Onchilles Pharma, and Hawthorne Effect closing in on millions of dollars worth of startup investments.

June 10, 2021
·
3 min read
·
Brandon May
Drug Development

Aducanumab Saga Continues as FDA Committee Members Resign Over Approval

David S. Knopman and Joel S. Perlmutter both resigned from the committee after the approval of the drug aducanumab.

June 10, 2021
·
5 min read
·
Mark Terry
Career Advice

Biotech In-Demand Jobs: Remote Workers

What are the benefits of becoming a remote worker? Let’s explore together.

June 10, 2021
·
4 min read
·
Kymberlie Krieger
Drug Development

South African HIV Patient Was a Natural Laboratory for SARS-CoV-2 Mutations

An immunocompromised patient in South Africa became a veritable COVID-19 variant laboratory as the virus mutated more than 30 times in 216 days of her infection, according to recent, not-yet-peer-reviewed research paper published in medRxiv.

June 10, 2021
·
4 min read
·
Gail Dutton
Business

Adaptive Phage Therapeutics Announces Collaboration with Oyster Point Pharma to Target Ophthalmic Diseases

Collaboration planned to develop therapeutics potentially targeting multiple ophthalmic diseases leveraging APT’s PhageBank™ technology.

June 10, 2021
·
8 min read
Genetown

AVROBIO to Present at the JMP Securities Life Sciences Conference

AVROBIO, Inc. today announced Geoff MacKay, president and CEO of AVROBIO, will present at the JMP Securities Life Sciences Conference at 10:30 a.m. ET on Thursday, June 17, 2021.

June 10, 2021
·
5 min read
Lone Star Bio

Taysha Gene Therapies to Host First Annual Stockholder Meeting

The Annual Stockholder Meeting on June 17, 2021 at 10 am ET.

June 10, 2021
·
1 min read